ABSTRACT-Introduction: The study investigated the effect of untreated cardiac arrest (CA), that is, ''no-flow'' time, on postresuscitation myocardial and neurological injury, and survival in a pig model to identify an optimal duration that adequately reflects the most frequent clinical scenario. Methods: An established model of myocardial infarction followed by CA and cardiopulmonary resuscitation was used. Twenty-two pigs were subjected to three no-flow durations: short (8-10 min), intermediate (12-13 min), and long (14-15 min). Left ventricular ejection fraction (LVEF) was assessed together with thermodilution cardiac output (CO) and high sensitivity cardiac troponin T (hs-cTnT). Neurological impairment was evaluated by neurological scores, serum neuron specific enolase (NSE), and histopathology. Results: More than 60% of animals survived when the duration of CA was 13 min, compared to only 20% for a duration !14 min. Neuronal degeneration and neurological scores showed a trend toward a worse recovery for longer no-flow durations. No animals achieved a good neurological recovery for a no-flow !14 min, in comparison to a 56% for a duration 13 min (P ¼ 0.043). Serum NSE levels significantly correlated with the no-flow duration (r ¼ 0.892). Longer durations of CA were characterized by lower LVEF and CO compared to shorter durations (P < 0.05). The longer was the no-flow time, the higher was the number of defibrillations delivered (P ¼ 0.043). The defibrillations delivered significantly correlated with LVEF and plasma hscTnT. Conclusions: Longer no-flow durations caused greater postresuscitation myocardial and neurological dysfunction and reduced survival. An untreated CA of 12-13 min may be an optimal choice for a clinically relevant model.
INTRODUCTION
Cardiac arrest (CA) is burdened by high mortality and severe neurological impairment among survivors (1) . Up to 64% of out-of-hospital (OH) CA victims die on the scene or on the way to the hospital during ambulance transport (2) . Moreover, more than half of the successfully resuscitated patients die within 72 h after hospital admission, such that final survival is approximately 8% in Europe, with great differences among countries (2) (3) (4) . Patients who eventually survive to hospital discharge frequently suffer from a persistent neurocognitive impairment that deeply impacts the quality of life (1, 4, 5) . Postcardiac arrest syndrome (PCAS) is responsible for these subsequent inhospital mortality and poor neurological outcome (3) .
Novel therapeutic approaches have been conceived and tested to improve outcome of CA. Indeed, experimental models represent the starting point for evaluating the effect of new interventions before their implementation into clinical practice. However, CA models are often not consistent in methods and experimental designs, such that their findings might be hardly reproduced in humans. An example is represented by the duration of untreated CA, known as ''no-flow'' time, that, although recognized as one of the main determinants of the PCAS severity, remains highly variable in the experimental studies (6) (7) (8) (9) (10) (11) . This potentially raises concerns on the adequacy of available experimental models in reflecting the real clinical scenario (12) .
Clinical studies report an average emergency medical service arrival time to the CA scene of 6-8 min; however, considering the intervals for emergency call, ambulance dispatch, arrival to the patient, and onset of cardiopulmonary resuscitation (CPR), it is reasonable that the no-flow duration accounts for even longer periods. Based on that, the duration of untreated CA in experimental models should reasonably last more than 8 min to The main focus of the present study is to provide evidence for designing more clinically relevant animal models, able to resemble CA outcomes similar to those reported in humans more recently, that is, a long-term survival with favorable neurological recovery in approximately 50% of resuscitated patients (4, 6) . Thus, the study systematically investigates the effect of different durations of untreated CA on postresuscitation myocardial and neurological injury and survival in a pig model of CPR with the aim to identify an optimal no-flow interval to be used for interventional experimental studies.
PATIENTS AND METHODS
All procedures involving animals and their care were in conformity with national and international laws and policies. Approval of the study was obtained by the institutional review board committee and governmental institution. To systematically investigate the effect on outcome of different durations of untreated CA, the present study includes data from an earlier investigation in which animals were subjected to 8 min of untreated CA (8) , and data from an immediately subsequent investigation directed to increase the duration of noflow up to a clinical relevant model (in term of survival and neurological recovery), in which animals were prospectively subjected to a duration of no-flow progressively increased from 10 to 12, 13, 14, and 15 min. Investigators and methods of induction of CA, of CPR, and measurements were the same in all the experiments.
Animal preparation
Twenty-two male domestic pigs (40 AE 1 kg) were fasted the night before experiment except for free water access. Anesthesia was induced by intramuscular injection of ketamine (20 mg/kg) followed by intravenous administration of propofol (2 mg/kg) and sufentanyl (0.3 mg/kg) through an ear vein access. Anesthesia was then maintained by continuous intravenous infusion of propofol (4-8 mg/kg/h) and sufentanyl (0.3 mg/kg/h). A cuffed tracheal tube was placed, and animals were mechanically ventilated with a tidal volume of 15 mL/kg and FiO 2 of 0.21. Respiratory frequency was adjusted to maintain the end-tidal partial pressure of carbon dioxide (EtCO 2 ) between 35 and 40 mmHg, monitored with an infrared capnometer (8) . For measurement of aortic pressure, a fluid-filled 7F catheter was advanced from the right femoral artery into the thoracic aorta. For measurements of right atrial pressure (RAP), core temperature, and cardiac output (CO), a 7F pentalumen thermodilution catheter was advanced from the right femoral vein into the pulmonary artery. Conventional pressure transducers were used (MedexTransStar, Monsey, NY). Myocardial infarction was induced in a closed-chest preparation by intraluminal occlusion of the left anterior descending (LAD) coronary artery (8) . More in details, a 6F balloon-tipped catheter was inserted from the right common carotid artery and advanced into the aorta and then into the LAD, beyond the first diagonal branch, with the aid of image intensification and confirmed by injection of radiographic contrast media. For inducing ventricular fibrillation (VF), a 5F pacing catheter was advanced from the right jugular vein into the right ventricle. The position of all catheters was confirmed by characteristic pressure morphology and/or fluoroscopy. Frontal plane electrocardiogram was recorded. Heart rate and rhythms were monitored by electrocardiograms.
Experimental procedure
The balloon of the LAD coronary artery catheter was then inflated with 0.7 mL of air to occlude the flow. Occlusion was confirmed by the rapid occurrence of progressive electrocardiographic ST segment elevation. If VF did not occur spontaneously, after 10 min it was induced with 1-2 mA AC current delivered to the right ventricle endocardium (8) . Ventilation was discontinued after the onset of VF. After 8-15 min of untreated VF, CPR, including chest compressions with the LUCAS 2 (PhysioControl Inc, Lund, Sweden) and ventilation with oxygen (tidal volume of 500 mL, 10 breaths/min), was initiated. More specifically, six pigs had a no-flow time of 8 min (8), two of 10 min, five of 12 min, three of 13 min, one of 14 min, and five of 15 min. For homogeneous comparison, animals were assigned to three groups of no-flow duration: ''short'' 8-10 min (n ¼ 8); ''intermediate'' 12-13 min (n ¼ 8); and ''long'' 14-15 (n ¼ 6). After 5 min of CPR, defibrillation was attempted with a single biphasic 150-J shock, using an MRx defibrillator (Philips Medical Systems, Andover, Mass). If resuscitation was not achieved, CPR was resumed and continued for 1 min before a subsequent defibrillation. Adrenaline (30 mg/kg) was administered via the right atrium after 2 and 7 min of CPR. The resuscitation procedures were continued until resuscitation or for a maximum of 15 min. Successful resuscitation was defined as restoration of an organized cardiac rhythm with a mean arterial pressure (MAP) of more than 60 mmHg. After that, if VF reoccurred, it was treated by immediate defibrillation. During CPR, the LAD occlusion balloon was deflated to avoid possible rupture during mechanical chest compression, but the catheter was left in place to maintain a partial occlusion of the LAD, which was approximately 75% of the internal lumen, as previously reported (17) . Immediately after resuscitation, the LAD occlusion balloon was reinflated and the catheter correct placement was reconfirmed by fluoroscopy. After successful resuscitation, anesthesia was maintained, and animals were monitored during the 4-h treatment. Forty-five minutes after resuscitation, the LAD catheter was withdrawn. Temperature of the animals was maintained at 38 AE 0.58C during the whole experiment. After 4 h of treatment, catheters were removed, wounds were repaired, and the animals were extubated and returned to their cages. Analgesia with butorphanol (0.1 mg/kg) was administered by intramuscular injection. At the end of the postresuscitation observation period, up to 96 h, animals were reanesthetized for echocardiographic examination and blood sample withdrawn. Animals were then sacrificed painlessly with an intravenous injection of 150 mg/kg sodium thiopental, and heart and brain were harvested. Autopsy was performed routinely for potential injuries due to CPR or obfuscating disease.
Measurements
Hemodynamics, EtCO 2 , and electrocardiogram were recorded continuously on a personal computer-based acquisition system (WinDaq DATAQ Instruments Inc, Akron, Ohio). The coronary perfusion pressure was computed from the differences in time-coincident diastolic aortic pressure and right atrial pressure. CO was measured by thermodilution technique (COM-2; Baxter International Inc, Deerfield, Ill). Echocardiography was performed using a phase-array multifrequency 2.5-to 5-MHz probe (CX50, Philips, The Netherlands), and left ventricular (LV) ejection fraction (EF) was calculated from twodimensional echocardiography from apical four chamber view using the modified single-plane Simpson's rule (8) . Arterial blood gases were assessed with i-STAT System (Abbott Laboratories, Princeton, NJ). Plasma high-sensitivity cardiac troponin T (hs-cTnT) and serum neuron-specific enolase (NSE) were measured with electrochemiluminescence assays (Roche Diagnostics Italia, Monza, Italy).
As previously described (8), neurologic recovery was assessed with the neurologic alertness score (NAS), ranging from 100 (normal) to 0 (brain death), and with the swine neurologic deficit score (NDS), ranging from 0 (normal) and 400 (brain death). Finally, the functional recovery was evaluated before sacrifice according to overall performance categories (OPCs) as follows: 1 ¼ normal, 2 ¼ slight disability, 3 ¼ severe disability, 4 ¼ coma, and 5 ¼ brain brain death or death. Outcome was defined poor when OPC was !3. Scores were assessed by veterinarian doctors blinded to no-flow duration.
At sacrifice, the brains were carefully removed from the skulls and fixed in 4% buffered formalin. Standardized 5-mm coronal slices were taken. The hippocampal CA1 sector and the cortex were chosen as regions of interest and were paraffin embedded. More specifically, the hippocampal CA1 sector was selected because it is well recognized to be associated with postresuscitation cognitive dysfunction in humans and animals (3, 8, 18, 19) . The cortex was selected to evaluate the effect of prolonged no-flow durations on cortical neurons, known to be more resistant to ischemia (18, 19) ; and have a histological correspondence with the neurological performances evaluated through the NAS and NDS scores, which are mainly related to the cortical responses. Five-micrometer-thick sections were then obtained and stained with hematoxylin-eosin. The proportion of neuronal loss and degeneration/necrosis (shrunken neurons with deeply acidophilic cytoplasm and pyknotic nucleus) was quantified as: absent (0), rare (1), few (2), and numerous (3). An experienced pathologist, blinded to treatment, performed the assessments. For transmission electron microscopy analysis, samples from hippocampus were reduced and fixed with 4% paraformaldehyde and 2% glutaraldehyde in phosphate buffer 0.12 mol/L pH 7.4 overnight at 48C, followed by incubation at room temperature for 2 h in 2% OsO 4 . After dehydration in a graded series of ethanol preparations, tissue samples were cleared in propylene oxide, embedded in epoxy medium (Epoxy Embedding Medium kit; Sigma-Aldrich) and polymerized at 608C for 72 h. Ultra-thin (60 nm thick) sections of areas of interest were obtained with a Leica EM UC6 ultramicrotome (Leica Microsystems), counterstained with uranyl acetate and lead citrate and examined with Energy Filter Transmission Electron Microscope (EFTEM, ZEISS LIBRA 120) equipped with YAG scintillator slow scan CCD camera.
Myocardial infarct was assessed by tetrazolium chloride (TTC) staining. The LV was sliced into 5-mm-thick transverse sections, which were incubated (20 min) in a solution of TTC and then transferred to 4% formalin overnight before image analysis. Infarct size was reported as percentage of TTC-negative area relative to LV area (8) .
Statistical analysis
One sample Kolmogorov-Smirnov Z test was used to confirm normal distribution of the data. For comparisons of time-based variables, repeated measures analysis of variance (ANOVA) was used. For comparisons between groups at the given time points, one-way ANOVA with Tukey's multiple comparison was used for normally distributed variables, while Kruskal-Wallis test with Dunn's multiple comparison was used for not normally distributed variables. When the dependent variable was categorical, chi-square test was performed. Linear correlations between parametric variables were calculated using the Pearson correlation coefficient. Spearman test was performed for the nonparametric variable correlation analyses. For survival analysis, KaplanMeier survival curves and log-rank (Mantel-Cox) test were used. Data are expressed as mean AE SEM, except for CPR duration, number of defibrillations delivered, hs-cTnT and NSE, presented as median [Q1-Q3]. A P 0.05 was regarded as statistically significant; for the multiple comparisons, the P value for statistical significance was adjusted to 0.017. Data analyses were performed using GraphPad Prism (version 6.05 for Windows; GraphPad Software, La Jolla, Calif).
RESULTS
No significant differences in hemodynamic parameters, EtCO 2 , cardiac function, and blood gases analysis were observed among groups at baseline ( Table 1 ). Duration of CPR was similar in the three groups (P not significant) and all animals were successfully resuscitated except for one animal in the long duration group. More than 80% of animals in the short and 60% in the intermediate no-flow duration survived up to 4 days, in contrast to only 20% in the long duration group (P ¼ 0.017 long vs. short; Table 1 and Fig. 1 ). The longer was the duration of no-flow, the higher was the total number of defibrillations delivered (r ¼ 0.497, P ¼ 0.02), with a 5-fold difference between the long and the short duration groups (Table 1 and Fig. 2 ).
Resuscitation outcome, postresuscitation hemodynamics, and blood gas analyses data are shown in Table 1 . No significant differences in MAP were observed among the groups, except for a trend toward a higher MAP in the short no-flow group compared to the others (Table 1) . Animals subjected to longer durations of no-flow presented significantly higher postresuscitation HR and RAP and a lower LV CO, compared to those in the shorter durations (P ¼ 0.040, P < 0.001, and P ¼ 0.032, respectively; Table 1 ).
LV EF decreased in each group after resuscitation (Fig. 2) . Postresuscitation LV EF was significantly lower in the longer duration groups compared to the shorter one (P < 0.05). LV EF at 4 h postresuscitation was inversely correlated with the duration of no-flow (r ¼ À0.65, P ¼ 0.006). As expected, an inverse relationship between LV EF and the number of delivered defibrillations was observed (r ¼ À0.52, P ¼ 0.038).
LV infarct size was comparable after short or intermediate duration of no-flow, while it was greater in the single animal that survived in the long duration group (Table 1 ). There was a trend toward higher plasma levels of hs-cTnT in the long duration group (Fig. 2) . Hs-cTnT release significantly correlated with the LV infarct size (r ¼ 0.77, P ¼ 0.004), but not with the duration of no-flow (r ¼ 0.225, P ¼ 0.37). Nevertheless, levels of hs-cTnT were significantly related to the number of defibrillations received by the animals (r ¼ 0.679, P ¼ 0.002).
Sixty-two percent of the animals resuscitated in the short and 50% in the intermediate no-flow duration group survived with a good neurological recovery (OPC 2), in contrast to no animals in the long duration group, in which only one of the five resuscitated animals survived and had an OPC of three (P ¼ 0.043, Fig. 3 ). NAS and NDS showed a trend toward a worse recovery for longer durations of no-flow, with the worst scores observed in the group with the longest duration of untreated CA (Fig. 3) . NSE release paralleled the trend observed in the neurological recovery, with higher circulating Copyright © 2017 by the Shock Society. Unauthorized reproduction of this article is prohibited. levels in the instance of longer durations of no-flow (P < 0.001, Fig. 2) . Indeed, the duration of untreated CA strongly correlated with NSE release (r ¼ 0.892, P < 0.001).
Neurological recovery and NSE data were confirmed by the histological findings, showing greater neuronal degeneration/ necrosis in hippocampus and in cortex for increasing noflow durations, with the single animal survived in the long duration group showing the most severe neuronal injury with associated gliosis and perivascular inflammation (Figs. 3 and 4) . Ultrastructural imaging showed mitochondria in neurons undergoing degenerative processes of increasing severity, that is, disruption of cristae and reduction of matrix density, for longer no-flow durations; neuropil, normally composed by a tightly packed myriad of axons, dendrites, and glial processes, also presented a progressive vacuolization and loss of structure (Fig. 5) .
DISCUSSION
The present study systematically investigated, for the first time, the effect of different no-flow intervals on PCAS severity in an experimental model, describing a linear association between the duration of untreated CA and the ensuing heart and brain injury. Indeed, longer no-flow durations were associated with lower percentage of survival and worse postresuscitation myocardial dysfunction and neurological recovery compared to shorter durations. However, the aim of the study was not to describe worse outcomes for longer no-flow durations, but rather to provide evidence and results that can be applied experimentally to design more clinically relevant studies. Showing increasing organ damage and lower survival for longer untreated CA durations was only the pragmatic way to deliver our message.
Duration of no-flow is one of the key features that deeply impact on CA survival and neurological injury (15, 16, (20) (21) (22) . Designing realistic models for preclinical research, with specific attention to the duration of untreated CA, is therefore crucial to correctly evaluate the potential benefit of new treatments. For this reason, the no-flow duration should be wisely selected to obtain an experimental model that closely reflects the human pathophysiology of CA and PCAS and whose observations might be easily translated clinically (12) . CA duration is, however, extremely variable in CPR models (7) (8) (9) (10) (11) . In a review including 42 experimental articles, significant differences in research methodology have been reported, highlighting a poor clinical representativeness for numerous studies. More specifically, the duration of untreated CA ranged from 0 to 15 min, with the majority of the experiments employing a duration as short as 3 min or even lesser (12) . In other recent reviews on animal models of CPR, longer no-flow intervals, close to 8 min, were reported (23, 24) . Nevertheless, our study showed that an untreated CA with a duration up to 10 min caused only a limited injury, which accounted for a survival in almost 90% of resuscitated animals. Only when the duration of no-flow exceeded 12 min, data on survival were similar to those reported clinically (25) .
Indeed, in our model, a duration of untreated CA of 12-13 min showed the best compromise in terms of survival and severity of myocardial and neurological injury, with outcomes that resembled those observed in the clinical scenario, that is, a long-term survival with favorable neurological outcome (OPC 1-2) in 50% of resuscitated animals (4, 6) . In contrast, for longer no-flow durations, that is, 14-15 min, 0% of animals survived with a good neurological recovery. Thus, considering clinical survival with good functional recovery, in our opinion an interval of 12-13 min may be an optimal choice for the duration of untreated CA to be used in experimental models, while with longer no-flow intervals, the mortality was unacceptably high. Moreover, in view of using a preclinical model to investigate new neuroprotective interventions, a CA duration !14 min determines probably a too extensive neuronal damage with important loss of ultrastructure, such that any potential benefit might be obfuscated.
The myocardial dysfunction observed after CA is a transient phenomenon due to cell stunning rather than permanent injury that usually spontaneously reverses within the following 2-3 days (3, 22, 26 ). In our model, the postresuscitation myocardial dysfunction, evaluated by LV EF, was deeply depressed in all groups of animals during the first 4 h postresuscitation, with a greater impairment after a CA duration !14 min. The worse myocardial dysfunction after a longer untreated CA may be explained as the result of a more severe ischemic insult, supported by the 2-fold greater infarct size in the single animal that survived and by the higher plasma hs-cTnTs in this group of animals. Another explanation may be represented by the greater number of defibrillations delivered to the animals (27) . Indeed, repetitive defibrillations are known to increase the severity of postresuscitation myocardial dysfunction (28) , and in our study, the longer was the duration of no-flow, the greater was the number of defibrillation attempts and such a number of electrical countershocks was significantly related with the systolic dysfunction, represented by the LV EF impairment, and with the myocardial injury, reported as hscTnT release.
We recognize several limitations in the interpretation of our findings. First, the study was not a randomized trial, but included data from an earlier investigation (8) , using the same model, and data from new investigations, in which animals were prospectively subjected to progressively longer durations of no-flow. However, the studies were performed consecutively, and investigators, methods for induction of CA, CPR procedures, and methodologies for measurements, were the same throughout the experiments such to allow for reproducibility and consistency of the results. Second, catheter-related thrombosis might develop very easily during the 45 min postresuscitation LAD occlusion because of the hypercoagulative feature of the porcine blood, potentially leading to emboli release during the LAD catheter withdraw. We decided not to administer heparin during the catheter removal to avoid potential impact on reperfusion; however, all the animals were subjected to the same procedure, limiting the effect of unexpected emboli on differences in outcome among groups. Third, the study did not assess the effect of different CPR or ''low-flow'' durations, which are known to potentially play a role in outcome (29) . Fourth, the effect of body temperature on neurological outcomes was not evaluated, although target temperature management (TTM) is currently a standard of care after OHCA for its beneficial effects on survival and neuroprotection (4, 30, 31) . Nevertheless, the quality of CPR was standardized and the duration of CPR was similar in all the groups. Moreover, all the animals received the same postresuscitation management, with the core temperature maintained at normothermia during the 4 h of intensive observation. Indeed, the main focus of the study was to assess the impact of the sole no-flow duration on outcome of CA, excluding any other potential bias, that is, TTM or duration of CPR. Therefore, our results are robust to show the direct impact of no-flow duration on the severity of PCAS and outcome of CA. Finally, we acknowledge that results from animal models of CA and CPR may be dependent on the local conditions and skills present in different laboratories. However, this article highlights the need for a standardization of procedures and may pave the route for a share of methodological details and adoption of experimental designs based on the clinical scenario.
The above limitations notwithstanding, in this porcine model, a linear relation between the duration of untreated CA and the severity of PCAS was observed. Indeed, longer no-flow durations caused greater postresuscitation myocardial and neurological dysfunction and reduced the survival rate, in comparison to shorter durations. A duration of untreated CA of 12-13 min may be an optimal choice for clinically relevant CA animal models because it yields survival rates and neurological outcomes similar to those observed in the clinical scenario.
